Terns Pharmaceuticals, Inc.TERNNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
0.00%
↑ 100% vs avg
Percentile
P25
Within normal range
Average
-986.96%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.00% | - |
| 2023 | 0.00% | - |
| 2022 | 0.00% | +100.0% |
| 2021 | -4934.80% | - |
| 2020 | 0.00% | - |